Why the study?
Does oral polio vaccine (OPV) compared to inactivated polio vaccine (IPV) increase the risk of paralytic disease in vaccinees?
Does oral polio vaccine (OPV) compared to inactivated polio vaccine (IPV) increase the risk of paralytic disease in vaccinees?
Answers are grounded in this paper and cite their sources.
The paper questions whether the risk of vaccine-induced paralytic disease from OPV justifies a return to IPV.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vincent A. Fulginiti (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: